An open label randomized controlled trial on the preemptive risedronate intervention for renal transplant patients receiving glucocorticoid

Trial Profile

An open label randomized controlled trial on the preemptive risedronate intervention for renal transplant patients receiving glucocorticoid

Recruiting
Phase of Trial: Phase III

Latest Information Update: 09 May 2017

At a glance

  • Drugs Risedronic acid (Primary) ; Vitamin D
  • Indications Corticosteroid-induced osteoporosis; Metabolic bone diseases
  • Focus Therapeutic Use
  • Acronyms PRIUS-RTx Study
  • Most Recent Events

    • 06 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top